Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 58 checked references that resolve
resolves10.1080/10643380500326564Advanced Oxidation Processes for Organic Contaminant Destruction Based on the Fenton Reaction and Related Chemistry
resolves10.1016/j.cej.2014.11.128Heterogeneous Fenton oxidation of 2,4-dichlorophenol using iron-based nanoparticles and persulfate system
resolves10.1021/ja409130cIron Oxychloride (FeOCl): An Efficient Fenton-Like Catalyst for Producing Hydroxyl Radicals in Degradation of Organic Contaminants
resolves10.1021/jacs.5b11561Cu<sup>2+</sup> Binds to Phosphatidylethanolamine and Increases Oxidation in Lipid Membranes
resolves10.1021/jacs.9b03457Synthesis of Copper Peroxide Nanodots for H<sub>2</sub>O<sub>2</sub> Self-Supplying Chemodynamic Therapy
resolves10.1002/anie.201712027Simultaneous Fenton‐like Ion Delivery and Glutathione Depletion by MnO<sub>2</sub>‐Based Nanoagent to Enhance Chemodynamic Therapy
resolves10.1039/B813725KMetal ion-catalyzed oxidative degradation of Orange II by H
<sub>2</sub>
O
<sub>2</sub>
. High catalytic activity of simple manganese salts
resolves10.1016/j.apcatb.2010.11.022Catalyzed oxidative degradation of methylene blue by in situ generated cobalt (II)-bicarbonate complexes with hydrogen peroxide
resolves10.1038/ejcn.2016.53Parenteral trace element provision: recent clinical research and practical conclusions
resolves10.1038/s41565-019-0406-1FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
resolves10.1186/s12878-016-0060-xFerumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia
resolves10.1039/c3cs60149hMagnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer
resolves10.1002/anie.201701181Activatable Singlet Oxygen Generation from Lipid Hydroperoxide Nanoparticles for Cancer Therapy
resolves10.7150/thno.5411Superparamagnetic Iron Oxide Nanoparticles: Amplifying ROS Stress to Improve Anticancer Drug Efficacy
resolves10.1021/acs.chemmater.6b03905Cellular Organelle-Dependent Cytotoxicity of Iron Oxide Nanoparticles and Its Implications for Cancer Diagnosis and Treatment: A Mechanistic Investigation
resolves10.1021/jacs.7b05559Continuous O<sub>2</sub>-Evolving MnFe<sub>2</sub>O<sub>4</sub> Nanoparticle-Anchored Mesoporous Silica Nanoparticles for Efficient Photodynamic Therapy in Hypoxic Cancer
resolves10.1021/jacs.7b11114A Facile Ion-Doping Strategy To Regulate Tumor Microenvironments for Enhanced Multimodal Tumor Theranostics
resolves10.1021/acs.nanolett.6b04269Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species
resolves10.1039/C9BM00641AA cascade-reaction enabled synergistic cancer starvation/ROS-mediated/chemo-therapy with an enzyme modified Fe-based MOF
resolves10.1002/anie.201710144Engineering Multifunctional RNAi Nanomedicine To Concurrently Target Cancer Hallmarks for Combinatorial Therapy
resolves10.1021/acs.nanolett.8b03905Amplification of Tumor Oxidative Stresses with Liposomal Fenton Catalyst and Glutathione Inhibitor for Enhanced Cancer Chemotherapy and Radiotherapy
resolves10.1021/acsnano.5b06175Ultrasound-Induced Reactive Oxygen Species Mediated Therapy and Imaging Using a Fenton Reaction Activable Polymersome
resolves10.1002/anie.201510031Synthesis of Iron Nanometallic Glasses and Their Application in Cancer Therapy by a Localized Fenton Reaction
resolves10.1021/ja063969hSynthesis and Stabilization of Monodisperse Fe Nanoparticles
resolves10.1002/anie.200700677Synthesis and Characterization of Monodisperse Hollow Fe<sub>3</sub>O<sub>4</sub> Nanoparticles
resolves10.1021/ja903300fPorous Hollow Fe<sub>3</sub>O<sub>4</sub> Nanoparticles for Targeted Delivery and Controlled Release of Cisplatin
resolves10.1021/ja905938aFePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition
resolves10.1039/b815548hMagnetic nanoparticles: synthesis, functionalization, and applications in bioimaging and magnetic energy storage
resolves10.1021/ar200090cMonodisperse Magnetic Nanoparticles for Theranostic Applications
resolves10.1016/j.tiv.2013.01.016Dichloro-dihydro-fluorescein diacetate (DCFH-DA) assay: A quantitative method for oxidative stress assessment of nanoparticle-treated cells
resolves10.21769/BioProtoc.3128Analysis of the Mitochondrial Membrane Potential Using the Cationic JC-1 Dye as a Sensitive Fluorescent Probe
resolves10.1038/nchembio.2239ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
resolves10.1182/blood.V97.3.792Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy
resolves10.1002/ana.25356N‐acetylcysteine targets 5 lipoxygenase‐derived, toxic lipids and can synergize with prostaglandin E
<sub>2</sub>
to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice
resolves10.1016/j.dental.2009.07.006N-Acetyl cysteine (NAC) inhibits proliferation, collagen gene transcription, and redox stress in rat palatal mucosal cells
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.